We explored the role of albumin in disaggregation and cellular uptake of Cycloimide Purpurin-18 (CIPp-18), an amphiphilic near-infrared PS, in human breast carcinoma (MCF-7) cells
If there is clinical improvement and if a reticulocyte response is observed, the same amount may be given on alternate days for seven doses, then every 3 to 4 days for another 2 to 3 weeks
You will answer a few questions about symptoms to help us prepare for your visit prior to scheduling your appointment
Potentially better outcomes than either alone
Timeframe Considerations: The company notes that consistent use over several weeks is typical before users may notice changes, if any occur
Sealed Vial: 10mg of Lyophilized Powder in 3ml Vial CAS No.: 137525-51-0 Other Names: Body Protection Compound-157, PL 14736, Pentadecapeptide BPC 157 This Product is Not For Human Consumption and is for Laboratory Use Only